Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer

Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer

Androgen deprivation therapy (ADT) with medical or surgical castration is the mainstay of therapy in men with metastatic prostate cancer. However, despite initial responses, almost all men eventually develop castration refractory metastatic prostate cancer (CRPC) and die of their disease. Over the l...

Full description

Bibliographic Details
Main Authors: Jesal C. Patel, Benjamin L. Maughan, Archana M. Agarwal, Julia A. Batten, Tian Y. Zhang, Neeraj Agarwal
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2013/981684

Internet

http://dx.doi.org/10.1155/2013/981684

Similar Items